Show simple item record

dc.contributor.authorFiorenza, S
dc.contributor.authorRoutledge, D
dc.contributor.authorCollins, J
dc.contributor.authorShipton, Michael J
dc.contributor.authorHarrison, S
dc.contributor.authorBajel, A
dc.contributor.authorCavet, James
dc.contributor.authorTholouli, E
dc.contributor.authorGauthier, J
dc.contributor.authorRitchie, D
dc.date.accessioned2019-10-07T15:16:39Z
dc.date.available2019-10-07T15:16:39Z
dc.date.issued2019en
dc.identifier.citationFiorenza S, Routledge D, Collins J, Shipton M, Harrison S, Bajel A, et al. Time from autologous to allogeneic hematopoietic stem cell transplantation impacts post-transplant outcomes in multiple myeloma. Bone Marrow Transplant. 2019 Sep 3.en
dc.identifier.pmid31481801en
dc.identifier.doi10.1038/s41409-019-0642-xen
dc.identifier.urihttp://hdl.handle.net/10541/622179
dc.language.isoenen
dc.relation.urlhttps://dx.doi.org/10.1038/s41409-019-0642-xen
dc.titleTime from autologous to allogeneic hematopoietic stem cell transplantation impacts post-transplant outcomes in multiple myelomaen
dc.typeArticleen
dc.contributor.departmentClinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USAen
dc.identifier.journalBone Marrow Transplantationen
dc.description.noteen]


This item appears in the following Collection(s)

Show simple item record